Accurate and rapid microfluidic ELISA to monitor Infliximab titers in patients with inflammatory bowel diseases

Literature Information

Publication Date 2021-12-30
DOI 10.1039/D1AN01810H
Impact Factor 4.616
Authors

Virginia Chu, João Gonçalves


View Original

Abstract

Inflammatory bowel disease (IBD) is a term used to describe disorders that involve chronic inflammation in the gastrointestinal tract, affecting more than 6.8 million people worldwide. Biological therapy is used in the most severe cases of IBD where anti-tumour necrosis factor-alpha (TNF-α) antibodies are the first choice for a biological treatment. When administrated to patients, these antibodies interact with TNF-α, usually overexpressed in these diseases, neutralizing its biological activity. Because of the chronic nature of these diseases, a recurring administration of the therapeutic antibodies is required, thus making therapy monitorization essential for the correct management of these diseases. The aim of this work is the development of an enzyme-linked immunosorbent assay (ELISA) microfluidic biosensor to quantify the therapeutic antibodies in IBD patient plasma samples, where the commercial monoclonal antibody Infliximab (IFX) is used as a model target. By providing a faster and more accurate measurement of IFX, the proposed method leads to improved therapy scheduling and a reduced risk of endogenous anti-drug antibodies (ADAs) reducing the efficacy of the treatment. The time needed between sample insertion and result output for the microfluidic ELISA (mELISA) is 24 minutes, drastically shorter than the time required by the conventional ELISA (cELISA). The mELISA presented in this work has a LoD of 0.026 μg mL−1, while commercially available solutions provide a LoD of 0.15 μg mL−1. Results acquired by the mELISA are highly correlated with the results obtained from the cELISA (r = 0.998; R2 = 0.996; p < 0.0001), demonstrating the validity of the microfluidic approach for the quantification of IFX from patient plasma and its potential for use at the point-of-care (POC).

Related Literature

Different thermal reactivity of a 1,2-thiaphospholo[a]phosphirane in free and metal carbonyl complexed form

Tamaki Jikyo, Gerhard Maas

2003-10-14 Communication

DOI: 10.1039/B310256D

Solvent-free ketone hydrogenations catalyzed by molybdenum complexes

Barbara F. M. Kimmich, Paul J. Fagan, Elisabeth Hauptman, R. Morris Bullock

2004-03-22 Communication

DOI: 10.1039/B401760A

A tyrosine-modified hypocrellin B with affinity for and photodamaging ability towards calf thymus DNA

Sheng Qin Xia, Jia Hong Zhou, Jing Rong Chen, Xue Song Wang, Bao Wen Zhang

2003-10-23 Communication

DOI: 10.1039/B309024H

Unexpected features of stretched Si–H⋯Mo β-agostic interactions‡

Stanislav K. Ignatov, Nicholas H. Rees, Stuart R. Dubberley, Alexei G. Razuvaev, Philip Mountford, Georgii I. Nikonov

2004-03-10 Communication

DOI: 10.1039/B315517J

A novel molecular ladder structure of Cu(ii)–Ba(ii) coordination polymer exhibiting ferromagnetic coupling

Yang Zou, Wenlong Liu, Song Gao, Jingli Xie, Qingjin Meng

2003-10-17 Communication

DOI: 10.1039/B308474D

Formation of a bifunctional zirconocene complex that favours intramolecular –B(C6F5)2 addition to a Cp ring over σ-ligand abstraction

Michael Hill, Gerald Kehr, Gerhard Erker, Olga Kataeva, Roland Fröhlich

2004-03-23 Communication

DOI: 10.1039/B400228H

Electrophilic terminal phosphinidene complex–Lewis base adducts: Chemistry between carbon–halide bond activation and weak Lewis base adduct formation

Arif Ali Khan, Cathleen Wismach, Peter G. Jones, Rainer Streubel

2003-10-22 Communication

DOI: 10.1039/B309443J

Patterning of DNA nanostructures on silicon surface by electron beam lithography of self-assembled monolayer

Guo-Jun Zhang, Takashi Tanii

2004-03-05 Communication

DOI: 10.1039/B315278B

Regioselective uncatalysed hydrophosphination of alkenes: a facile route to P-alkylated phosphine derivatives

Olivier Delacroix, Annie-Claude Gaumont

2003-10-29 Communication

DOI: 10.1039/B311892D

Using two photonmicroscopy to quantify enzymatic reaction rates on polymer beads

Annie Y. Bosma, Gail McConnell, John Girkin, Peter J. Halling, Sabine L. Flitsch

2003-10-13 Communication

DOI: 10.1039/B308078A

You might also like

Compound Q&A

What is the market or research trend for N-(4-Methoxybenzyl)-2-pyridinamine (CAS: 52818-63-0)?

N-(4-Methoxybenzyl)-2-pyridinamine (CAS: 52818-63-0) is increasingly being used ...

52818-63-0N-(4-Methoxybenzyl)-...
Compound Q&A

What precautions should be taken when handling Ethyl 4-(2-chlorophenyl)-1,3-thiazole-2-carboxylate (CAS: 1050507-06-6)?

When handling Ethyl 4-(2-chlorophenyl)-1,3-thiazole-2-carboxylate, appropriate p...

1050507-06-6Ethyl 4-(2-chlorophe...
Compound Q&A

What regulatory guidelines apply to diethyldiselane (CAS: 628-39-7)?

Diethyldiselane (CAS: 628-39-7) is classified under the Globally Harmonized Syst...

628-39-7Diethyldiselane
Compound Q&A

What is the market or research trend for oxocopper (CAS: 12053-18-8)?

The market for oxocopper (CAS: 12053-18-8) is primarily driven by its use in cat...

12053-18-8oxocopper; oxo-(oxoc...
Compound Q&A

What is the market or research trend for 5-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-azaspiro[2.4]heptane-7-carboxylic acid?

The market for 5-{[(2-Methyl-2-propanyl)oxy]carbonyl}-5-azaspiro[2.4]heptane-7-c...

1268519-54-55-{[(2-Methyl-2-prop...
Compound Q&A

What is 2-(1-Pyrrolidinyl)-4-pyridinamine (CAS: 35981-63-6)?

2-(1-Pyrrolidinyl)-4-pyridinamine is a chemical compound with the CAS number 359...

35981-63-62-(1-Pyrrolidinyl)-4...
Compound Q&A

What are the physical and chemical properties of 2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane (CAS: 91556-75-1)?

2-(3-Pyridinyl)-1-azabicyclo[2.2.2]octane (CAS: 91556-75-1) is a crystalline sol...

91556-75-12-(3-Pyridinyl)-1-az...
Compound Q&A

How is (S)-Alpha-allyl-proline hydrochloride (CAS: 129704-91-2) typically synthesized?

(S)-Alpha-allyl-proline hydrochloride is usually synthesized via a Wittig reacti...

129704-91-2(S)-Alpha-allyl-prol...
Compound Q&A

What is 3-Methyl-1,2-oxazole-5-carboxylic acid (CAS: 4857-42-5)?

3-Methyl-1,2-oxazole-5-carboxylic acid (CAS: 4857-42-5) is an organic compound w...

4857-42-53-Methyl-1,2-oxazole...
Compound Q&A

How is Lys-SMCC-DM1 (CAS: 1281816-04-3) typically synthesized?

Lys-SMCC-DM1 is synthesized via a multi-step process involving the coupling of S...

1281816-04-3Lys-SMCC-DM1

Source Journal

Analyst

Analyst
CiteScore: 7.8
Self-citation Rate: 5.6%
Articles per Year: 653

Analyst publishes analytical and bioanalytical research that reports premier fundamental discoveries and inventions, and the applications of those discoveries, unconfined by traditional discipline barriers.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.